Dino Mustafić

January 30, 2018 Off

Beximco increases profit in Q2 2017

The London-listed Bangladesh-based pharmaceutical company, Beximco, has had net sales in the second quarter increased 12.8% to BDT 4,359.9m /…

January 30, 2018 Off

AB Biosciences, Shire in licence deal

By Dino Mustafić

AB Biosciences will grant Shire an exclusive worldwide license to develop and commercialize AB Biosciences’ pan receptor interacting molecule (PRIM)…

January 29, 2018 Off

Sanofi buys Ablynx for €3,9 billion

By Dino Mustafić

Sanofi will buy Belgian Nanobody technology specialist Ablynx for €3.9 billion, it was announced Monday by both companies.

January 29, 2018 Off

Bormioli Pharma packaging innovations finds solution to unstable drug formulations

By Dino Mustafić

This year’s Pharmapack Conference sees Bormioli Pharma, one of the world’s leading glass and plastic packaging manufacturers for the pharmaceutical sector, make a…

January 29, 2018 Off

Santhera reports net revenues 21% up in 2017 from its lead product Raxone, amid negative opinion by CHMP for it in DMD

By Dino Mustafić

Santhera Pharmaceuticals has reported an increase of 21% year-on-year in net revenues to CHF 22.9 million (2016: CHF 19.0 million)…

January 29, 2018 Off

Faron’s Traumakine on Fast Track, as the US FDA says it’s good to go

By Dino Mustafić

Faron Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for Traumakine, which also has…

January 29, 2018 Off

OxforD BioDynamics develops with Holos Life Sciences biomarkers for sport-related concussions

By Dino Mustafić

Oxford BioDynamics and Holos Life Sciences will together develop non-invasive epigenetic biomarkers associated with sports-related concussions, Oxford said Monday.